DNMT3A and Miyoshi myopathy: reported an inverse correlation between miR-29b and DNMT3B levels and showed that targeting DNMT3A/B using miR-29b mimics reduces MM cell growth, indicating that DNMT3A/B has an oncogenic role in MM (138).